AIM-HI Accelerator provides oncology-focused mentorship, clinical and IP guidance, educational and legal workshops, investor and pharma introductions, regulatory support, and global industry exposure.

We typically invest up to $1M per startup in exchange for a negotiated equity stake, with the exact percentage determined by the startup’s valuation and deal terms, potentially ranging from 5%–20%+ depending on stage and valuation.

Provides hard-tech startups with strategic mentorship, enterprise customer introductions, co-investor network access, manufacturing and supply chain support, commercialization guidance, and board-level expertise to help scale advanced technology companies.

We typically invest $1M–$10M per round across Seed to early-growth stages, targeting ~10%–20% equity in lead investments (and ~5%–10% in co-investment scenarios), with larger participation in Series A–B rounds depending on valuation and syndicate structure.

Provides equity-free mentorship and training, eligibility for $50K–$150K non-dilutive grants, workspace access, expert coaching, investor and partner introductions, and marketing support through its storytelling network.

No typical fee

Our unique differentiation is our ability to help founders land their first enterprise clients. In a world where distribution is critical, we suss out who has the tech and go-to-market strategy to significantly scale. Our deal flow is uniquely differentiated, with 80% of our investments stemming from referrals by other founders.